Skip to content

13F-HR filed by Lamond Capital Partners LLC

Lamond Capital Partners LLC filed this 13F-HR for the quarter ended 2015-06-30, filed 2015-08-07, with 11 holding rows worth $98,504,000.

Accession
0001542550-15-000004
Filed
2015-08-07
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2015

A holdings report, 11 entries on the cover page, a total value of $98,504,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $98,504,000 with VALUE read as thousands by filing date, 13F file number 028-15156. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
OCULAR THERAPEUTIX INC67576A100COM711,533$14,964,000thousands by filing date
Amgen Inc.031162100COM96,630$14,835,000thousands by filing date
AXOVANT SCIENCES LTDG0750W104COM692,961$14,123,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM56,610$10,233,000thousands by filing date
HEWLETT PACKARD CO428236103COM337,000$10,113,000thousands by filing date
VIOLIN MEMORY I92763A101Common Stock3,934,580$9,640,000thousands by filing date
HORNBECK OFFSHORE SVCS INC N440543106COM352,720$7,241,000thousands by filing date
KITE PHARMA INC49803L109COM105,498$6,432,000thousands by filing date
INFOBLOX INC45672H104COM230,872$6,051,000thousands by filing date
NIVALIS THERAPEUTICS INC65481J109COM225,000$3,409,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM68,780$1,463,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001542550-15-000004this filing2015-08-07acceptance time not in the bulk data set